THE ROLE OF MACROPHAGE LYSOSOMAL BIOGENESIS IN ATHEROSCLEROSIS
THE ROLE OF MACROPHAGE LYSOSOMAL BIOGENESIS IN ATHEROSCLEROSIS
批准号:
8801613
负责人:
Babak Razani
金额:
$38.13万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2014
资助国家:
美国
项目状态:
已结题
起止时间:
2014-11-04 至 2019-10-31
关键词:
AddressAreaArterial Fatty StreakAtherosclerosisAutophagocytosisBiogenesisCardiovascular DiseasesCause of DeathCell physiologyCellsCholesterolComplexCoronary ArteriosclerosisDataDepositionDigestionDiseaseEnvironmentEventExposure toFoam CellsFunctional disorderFutureGenesGoalsHyperlipidemiaImpairmentIn VitroInfiltrationInflammatoryInvestigationLearningLinkLipidsLipoprotein ReceptorLysosomesMediatingMediator of activation proteinModelingModificationMorbidity - disease rateMusMyocardial InfarctionNuclear TranslocationOrganellesPathogenesisPathway interactionsPhagocytosisPhenotypeProcessProteinsRegulationReportingResearchRisk FactorsRoleSignal PathwaySignal TransductionSirolimusStressStrokeSystemTestingTherapeuticUnited StatesVascular Systematherogenesisatheroprotectivebasedetection of nutrienthuman FRAP1 proteinin vivoinsightinterestlipid metabolismmTOR Inhibitormacrophagemembermortalitymouse modelnoveloverexpressionoxidized low density lipoproteinprogramspublic health relevancereceptor mediated endocytosisresponsetooltranscription factortreatment strategyuptake
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Atherosclerotic vascular disease remains the leading cause of death in the United States with the majority of mortality due to coronary artery disease and myocardial infarction. Risk factor modification such as reductions in hyperlipidemia constitutes the only treatment strategy available for this vexing disease. Thus, there is an active
effort to identify the culprit cellular processes that provide mechanistic insight. Recent reports f the proatherogenic phenotype of mice with a macrophage-specific autophagy deficiency has renewed interest in the role of the autophagy-lysosomal system in atherosclerosis. Lysosomes have the unique role of processing both exogenous material such as excess atherogenic lipids and endogenous cargo that includes dysfunctional proteins and organelles. Since little is known about the effect of an atherogenic environment on macrophage lysosomes, we aimed to test the notion that lysosomal dysfunction is the product of lipid metabolism and evaluate novel ways to ameliorate this effect. Our preliminary data demonstrate that macrophages develop features of lysosome dysfunction upon exposure to atherogenic lipids. In turn, this lysosomal stress can activate TFEB, the only known transcription factor that can broadly stimulate lysosomal biogenesis and function. The regulation of macrophage TFEB appears to be critically linked to mTOR signaling, buttressed by the observation that the classic mTOR inhibitor Rapamycin can induce lysosomal biogenesis while reducing macrophage dysfunction and atherosclerosis. Understanding the links between lipid metabolism and lysosomal biogenesis has important implications in understanding plaque progression. We propose to test the hypothesis that macrophage lysosomal biogenesis mediated by the transcription factor TFEB is an important compensatory response during atherosclerosis and serves an atheroprotective role. A variety of mouse models capable of dissecting the role of TFEB action in macrophages will serve as the research tools to address this hypothesis both in vitro and in vivo.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Harnessing the Autophagy-Lysosomal Biogenesis Response in Macrophages to Treat Atherosclerosis
-
批准号:10370137
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2018
-
负责人:Babak Razani
-
依托单位:
Harnessing the Autophagy-Lysosomal Biogenesis Response in Macrophages to Treat Atherosclerosis
-
批准号:10549729
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2018
-
负责人:Babak Razani
-
依托单位:
Harnessing the Autophagy-Lysosomal Biogenesis Response in Macrophages to Treat Atherosclerosis
-
批准号:10265332
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2018
-
负责人:Babak Razani
-
依托单位:
Clearance of macrophage p62-enriched protein aggregates as a therapy for atherosclerosis
-
批准号:10732859
-
项目类别:
-
资助金额:$39.37万
-
财政年份:2014
-
负责人:Babak Razani
-
依托单位:
Clearance of macrophage p62-enriched protein aggregates as a therapy for Atherosclerosis
-
批准号:10214664
-
项目类别:
-
资助金额:$39.38万
-
财政年份:2014
-
负责人:Babak Razani
-
依托单位:
Clearance of macrophage p62-enriched protein aggregates as a therapy for Atherosclerosis
-
批准号:10428518
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2014
-
负责人:Babak Razani
-
依托单位:
THE ROLE OF MACROPHAGE LYSOSOMAL BIOGENESIS IN ATHEROSCLEROSIS
-
批准号:8962169
-
项目类别:
-
资助金额:$38.13万
-
财政年份:2014
-
负责人:Babak Razani
-
依托单位:
Clearance of macrophage p62-enriched protein aggregates as a therapy for atherosclerosis
-
批准号:10649536
-
项目类别:
-
资助金额:$39.75万
-
财政年份:2014
-
负责人:Babak Razani
-
依托单位:
De Novo Lipogenesis in Myocardial Dysfunction
-
批准号:8469343
-
项目类别:
-
资助金额:$11.78万
-
财政年份:2010
-
负责人:Babak Razani
-
依托单位:
De Novo Lipogenesis in Myocardial Dysfunction
-
批准号:8106261
-
项目类别:
-
资助金额:$11.78万
-
财政年份:2010
-
负责人:Babak Razani
-
依托单位:
De Novo Lipogenesis in Myocardial Dysfunction
-
批准号:8678724
-
项目类别:
-
资助金额:$11.78万
-
财政年份:2010
-
负责人:Babak Razani
-
依托单位:
De Novo Lipogenesis in Myocardial Dysfunction
-
批准号:8277896
-
项目类别:
-
资助金额:$11.78万
-
财政年份:2010
-
负责人:Babak Razani
-
依托单位:
De Novo Lipogenesis in Myocardial Dysfunction
-
批准号:7771999
-
项目类别:
-
资助金额:$11.78万
-
财政年份:2010
-
负责人:Babak Razani
-
依托单位:
国内基金
海外基金
层出镰刀菌氮代谢调控因子AreA 介导伏马菌素 FB1 生物合成的作用机理
-
批准号:2021JJ40433
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2021
-
负责人:孙磊
-
依托单位:
寄主诱导梢腐病菌AreA和CYP51基因沉默增强甘蔗抗病性机制解析
-
批准号:32001603
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:段真珍
-
依托单位:
AREA国际经济模型的移植.改进和应用
-
批准号:18870435
-
项目类别:面上项目
-
资助金额:2.0万元
-
批准年份:1988
-
负责人:史树中
-
依托单位: